Inventor
Henning Steinhagen
Inventor
Sulzbach, DE
Overview
Patents· 26 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations41%
C07DHeterocyclic compounds41%
C07CAcyclic or carbocyclic compounds10%
A61KPreparations for medical, dental or toiletry purposes8%
PatentTitleYear
9,802,947'3-oxo-tetrahydro-furo[3,2-b]pyrrol-4(5H)-yl) derivatives II'20179,802,921'Fluoromethyl-substituted pyrrole carboxamides iv'20179,725,459'3-oxo-tetrahydro-furo[3,2-B]pyrrol-4(5H)-yl) derivatives I'20179,562,036'Fluoromethyl-substituted pyrrole carboxamides as CaV2.2 calcium channel blockers'20179,302,988'Fluoromethyl-substituted pyrrole carboxamides'20169,079,906'Triazolopyridazines as PAR1 inhibitors, production thereof, and use as medicaments'20158,871,798'Tricyclic pyridyl-vinyl pyrroles as PAR1 inhibitors'20148,853,206'Triazolium salts as PAR1 inhibitors, production thereof, and use as medicaments'20148,791,133'Pyridylvinylpyrazoloquinolines as PAR1 inhibitors'20148,598,177'Imidazopyridazines as PAR1 inhibitors, production thereof, and use as medicaments'20138,580,813'Cyclic azaindole-3-carboxamides, their preparation and their use as pharmaceuticals'20138,466,169'SF5 derivatives as PAR1 inhibitors, production thereof, and use as medicaments'20138,415,336'Cyclic (aza)indolizinecarboxamides, their preparation and their use as pharmaceuticals'20138,263,621'Tartrate derivatives for use as coagulation factor IXa inhibitors'20128,211,885'Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals'20128,198,272'Triazolium salts as PAR1 inhibitors, production thereof, and use as medicaments'20128,153,647'Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics'20128,143,242'Malonamide derivatives with antithrombotic activity'20128,097,758'Isoserine derivatives for use as coagulation factor IXa inhibitors'20128,076,336'Triazolopyridazines as PAR1 inhibitors, production thereof, and use as medicaments'20117,910,602'Pyrazolopyridine derivatives as inhibitors of β-Adrenergic receptor kinase 1'20117,125,995'Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (PARS)'20067,074,780'Substituted phenylcyclohexanecarboxamides and their use'20066,984,642'Substituted phenylcyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors'20066,649,618'Substituted amidoalkyl-uracils and their use'20036,649,616'Substituted phenylcyclohexanecarboxamides and their use'2003Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2003–2006Based in Wuppertal, DE· patent location history
2006–2016Based in Sulzbach, DE· patent location history
2011–2015Patents assigned to STEINHAGEN HENNING (13)· patent assignee history
2011–2012Patents assigned to SANOFI AVENTIS (7)· patent assignee history
2011–2015Patents assigned to WEHNER VOLKMAR (7)· patent assignee history
2011–2015Patents assigned to HEINELT UWE (6)· patent assignee history
2011–2012Based in Frankfurt am Main, DE· patent location history
2012–2015Patents assigned to SANOFI SA (9)· patent assignee history
2014Based in Schwalbach am Taunus, DE· patent location history
2017Based in Schwalbach, DE· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| STEINHAGEN HENNINGself | 13 | 2011–2015 |
| SANOFI SA | 9 | 2012–2015 |
| SANOFI AVENTIS | 7 | 2011–2012 |
| WEHNER VOLKMAR | 7 | 2011–2015 |
| HEINELT UWE | 6 | 2011–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Sulzbach, DE | 14 | 2006–2016 |
| Schwalbach, DE | 4 | 2017 |
| Wuppertal, DE | 4 | 2003–2006 |
| Schwalbach am Taunus, DE | 2 | 2014 |
| Frankfurt am Main, DE | 2 | 2011–2012 |